News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Turner Heather D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2018 |
4
| Turner Heather D (SVP and General Counsel) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 200,000 options to buy
@ $23.95, valued at
$4.8M
|
|
| 02/16/2018 |
3
| Turner Heather D (SVP and General Counsel) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 02/12/2018 |
4
| Turner Heather D (Former EVP, GC & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Sold 4,596 shares
@ $36.63, valued at
$168.4k
Sold 4,123 shares
@ $37.38, valued at
$154.1k
Sold 600 shares
@ $38.63, valued at
$23.2k
Sold 733 shares
@ $39.66, valued at
$29.1k
Sold 600 shares
@ $40.62, valued at
$24.4k
Sold 1,562 shares
@ $41.69, valued at
$65.1k
|
|
| 02/08/2018 |
4
| Turner Heather D (EVP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,434 shares
@ $35.8, valued at
$158.7k
|
|
| 02/10/2017 |
4
| Turner Heather D (EVP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc. |
| 02/08/2017 |
4
| Turner Heather D (EVP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc. |
| 09/23/2016 |
4
| Turner Heather D (VP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc. |
| 03/04/2016 |
4
| Turner Heather D (VP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $56.98, valued at
$7.4M
|
|
| 02/11/2016 |
4
| Turner Heather D (VP, General Counsel & Sec.) has filed a Form 4 on Atara Biotherapeutics, Inc.|
Txns:
| Granted 48,857 shares
@ $0 |
|
| 12/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2015 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 153,050 options to buy
@ $5.34, valued at
$817.3k
|
|
| 12/04/2014 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 22,643 shares
@ $6, valued at
$135.9k
Exercised 22,643 options to buy
@ $1.66, valued at
$37.6k
|
|
| 11/26/2014 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 24,006 shares
@ $5.773, valued at
$138.6k
Sold 7,382 shares
@ $6, valued at
$44.3k
Exercised 24,006 options to buy
@ $1.66, valued at
$39.8k
Exercised 7,382 options to buy
@ $1.66, valued at
$12.3k
|
|
| 09/22/2014 |
4
| Turner Heather D (VP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 300,000 shares
@ $4.465, valued at
$1.3M
Exercised 300,000 options to buy
@ $1.66, valued at
$498k
|
|
| 02/11/2014 |
4
| Turner Heather D (VP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 3,980 shares
@ $5.34, valued at
$21.3k
Granted 205,000 options to buy
@ $6.3, valued at
$1.3M
|
|
| 02/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/19/2012 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Sold 82,433 shares
@ $7.6844, valued at
$633.4k
Exercised 82,433 options to buy
@ $1.66, valued at
$136.8k
|
|
| 01/26/2012 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $2.58, valued at
$903k
|
|
| 07/26/2011 |
4
| Turner Heather D (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 1,093,396 options to buy
@ $1.66, valued at
$1.8M
Disposed/sold 130,000 options to buy
@ $15.45, valued at
$2M
Disposed/sold 16,000 options to buy
@ $14.26, valued at
$228.2k
Disposed/sold 100,000 options to buy
@ $11.34, valued at
$1.1M
Disposed/sold 38,951 options to buy
@ $4.03, valued at
$157k
Disposed/sold 91,445 options to buy
@ $2.13, valued at
$194.8k
Disposed/sold 115,000 options to buy
@ $6.74, valued at
$775.1k
Disposed/sold 45,000 options to buy
@ $2.94, valued at
$132.3k
Disposed/sold 107,000 options to buy
@ $2.94, valued at
$314.6k
Disposed/sold 450,000 options to buy
@ $1.7, valued at
$765k
|
|
| 03/04/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/26/2010 |
4
| Turner Heather D (VP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $6.74, valued at
$775.1k
|
|
| 04/27/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 01/28/2009 |
4
| Turner Heather D (VP, Gen. Counsel & Secretary) has filed a Form 4 on Orexigen Therapeutics, Inc. |
|
|